US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

671.18

+9.191.39%

Number of Gainers:93

Number of Losers:52

Number of Flat:8

PE:- -

High:673.52

Open:662.15

Low:661.43

Close:662.00

Volume:287.29M

Turnover:7.82B

Market Cap:464.24B

Float Cap:356.88B

Loading ...

Aquestive Therapeutics Adds Veteran Executive to Board

Zhihu-W (02390) Spends US$265,100 to Buy Back 207,900 Shares on September 28

Invivyd Plans FDA Accelerated-Approval BLA Filing for Vyd2311 COVID Antibody

Deutsche Bank Trims Price Target on Robinhood Markets to $134 From $138, Keeps Buy Rating

MT Newswires Live

Unicycive Therapeutics announces resubmission of NDA for OLC

Aquestive Therapeutics appoints Daly to board of directors

Unicycive Resubmits FDA NDA for Oxylanthanum Carbonate Phosphate Binder

Unicycive Therapeutics - FDA Acceptance of Nda Expected Within 30 Days; New Pdufa Date in 6 Months

THOMSON REUTERS

Unicycive Therapeutics - Nda Resubmission Includes Cmc Data from New Manufacturing Vendor

THOMSON REUTERS

Unicycive Therapeutics Announces Resubmission of New Drug Application for Oxylanthanum Carbonate

THOMSON REUTERS

Unicycive Therapeutics - FDA Inspection of Original Manufacturing Vendor Assigned but not Completed as of Sept 29, 2026

THOMSON REUTERS

Invivyd Says Liberty Phase 3 Trial Shows Vyd2311 Safety, Tolerability Top mRNA COVID-19 Vaccine

Invivyd, - Vyd2311 Combined with Mrna Covid-19 Vaccine Adds to Neutralizing Titers Without Interference

THOMSON REUTERS

Invivyd, - Plans Bla Submission for Vyd2311 to FDA Via Accelerated Approval Program

THOMSON REUTERS

Invivyd Announces Positive Topline Results from Liberty Phase 3 Study Demonstrating Vyd2311 Safety and Tolerability Superior to Mrna-Based Covid-19 Vaccine; Announces Regulatory Submission Plans for Vyd2311

THOMSON REUTERS

Press Release: Aquestive Therapeutics Strengthens Board of Directors with Appointment of Richard Daly

Alzamend Neuro Highlights Early AL001 Brain Lithium Data

Presidio Names J. Michael Bruff CFO Effective Oct. 5

Summit Therapeutics secures major AstraZeneca equity partnership

Analysts Conflicted on These Technology Names: Duolingo (DUOL), Advanced Micro Devices (AMD) and Draganfly (DPRO)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/BK4539/news?page=35"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":671.1836,"timestamp":1791575999999,"preClose":661.99634,"halted":0,"volume":287285023,"delay":0,"changeRate":0.013878,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":9.187256,"latestTime":"10-09 16:00:00 EDT","open":662.1523,"high":673.518,"low":661.43115,"amount":7816485727.833852,"amplitude":0.018258,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.138586,"peRate":113.608055,"turnoverRate":0.022513,"increases":93,"decrements":52,"flats":5,"marketCap":464240508630.96875,"floatMarketCap":356880187889.46875},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":673.518,"amplitude":0.018258,"preClose":661.99634,"low":661.43115,"pbRate":"5.138586","latestPrice":671.1836,"volume":287285023,"delay":0,"open":662.1523,"prevYearClose":881.5255,"prevWeekClose":665.7447,"prevMonthClose":677.2829,"prevQuarterClose":677.2829,"fiveDayClose":665.7447,"twentyDayClose":693.0266,"sixtyDayClose":732.057,"secType":"PLATE","market":"US","turnoverRate":0.022513,"peRate":113.608055,"marketCap":464240508630.96875,"floatMarketCap":356880187889.46875,"timestamp":1791575999999,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":93,"down":52,"flat":8},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:35,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671211508","title":"Aquestive Therapeutics Adds Veteran Executive to Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2671211508","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671211508?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:49","pubTimestamp":1790682582,"startTime":"0","endTime":"0","summary":"Aquestive Therapeutics ( ($AQST) ) has provided an update. On September 29, 2026, Aquestive Therapeutics announced that its board had elected veter...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aquestive-therapeutics-adds-veteran-executive-to-board?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aquestive-therapeutics-adds-veteran-executive-to-board?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4007","BK4539","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198995429","title":"Zhihu-W (02390) Spends US$265,100 to Buy Back 207,900 Shares on September 28","url":"https://stock-news.laohu8.com/highlight/detail?id=1198995429","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198995429?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:38","pubTimestamp":1790681892,"startTime":"0","endTime":"0","summary":"Zhihu-W (02390) has announced that on September 28, 2026, the company spent US$265,100 to repurchase 207,900 shares, at a repurchase price of HK$1.25 to HK$1.2933 per share.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4509","HK0000252152.HKD","02390","HK0000500386.USD","HK0000252160.HKD","ZH","BK4077","BK4539","BK1095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671216770","title":"Invivyd Plans FDA Accelerated-Approval BLA Filing for Vyd2311 COVID Antibody","url":"https://stock-news.laohu8.com/highlight/detail?id=2671216770","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671216770?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:28","pubTimestamp":1790681317,"startTime":"0","endTime":"0","summary":"Invivyd plans FDA accelerated-approval BLA filing for VYD2311 COVID antibodyInvivyd set plans to file a U.S. FDA Biologics License Application for COVID-19 antibody VYD2311 via the Accelerated Approva","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL4XrsY1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","IVVD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671216711","title":"Deutsche Bank Trims Price Target on Robinhood Markets to $134 From $138, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2671216711","media":"MT Newswires Live","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671216711?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:25","pubTimestamp":1790681148,"startTime":"0","endTime":"0","summary":"Robinhood Markets (HOOD) has an average rating of overweight and mean price target of $134.74, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HOOZ","IAI","ROBN","HOYY","LU1861558580.USD","HOOY","BK4547","HOOC","HOOG","HOOI","BK4539","FINX","LU1861559042.SGD","HOOW","BLCK","CRPT","HOOX","BK4127","BPAY","HOII","HODU","HOOD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671216406","title":"Unicycive Therapeutics announces resubmission of NDA for OLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2671216406","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671216406?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:15","pubTimestamp":1790680531,"startTime":"0","endTime":"0","summary":"Unicycive Therapeutics (UNCY) announced the resubmission of its New Drug Application, NDA, for oxylanthanum carbonate, OLC, the Company’s investiga...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/unicycive-therapeutics-announces-resubmission-of-nda-for-olc-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/unicycive-therapeutics-announces-resubmission-of-nda-for-olc-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","UNCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671921643","title":"Aquestive Therapeutics appoints Daly to board of directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2671921643","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671921643?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:10","pubTimestamp":1790680210,"startTime":"0","endTime":"0","summary":"Aquestive Therapeutics (AQST) announced the appointment of Rich Daly to the Company’s Board of Directors, effective October 14, 2026. Following Mr....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aquestive-therapeutics-appoints-daly-to-board-of-directors-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aquestive-therapeutics-appoints-daly-to-board-of-directors-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LENZ","BK4539","AQST","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671421639","title":"Unicycive Resubmits FDA NDA for Oxylanthanum Carbonate Phosphate Binder","url":"https://stock-news.laohu8.com/highlight/detail?id=2671421639","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671421639?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:05","pubTimestamp":1790679917,"startTime":"0","endTime":"0","summary":"Unicycive resubmits FDA NDA for oxylanthanum carbonate phosphate binderUnicycive resubmitted its FDA NDA for oxylanthanum carbonate to treat hyperphosphatemia in CKD patients on dialysis.Filing includ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL2RqzJF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","SG9999014021.USD","BK4112","IE00BQXX3D17.EUR","BK4139","IE00BQXX3F31.USD","LU2095319765.USD","NDAQ","BK4588","IE00B64PRP62.GBP","LU0314104364.USD","LU2210149790.SGD","SG9999014013.SGD","IE00BGHQF748.EUR","IE00BN0W2W23.USD","IE00BQXX3C00.GBP","IE00BN0W2V16.EUR","LU2210150020.SGD","BK4585","IE00BKPKM429.USD","IE00B3QW5Z07.USD","SG9999014005.SGD","IE00BN0W2T93.GBP","BK4539","UNCY","BCDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671521637","title":"Unicycive Therapeutics - FDA Acceptance of Nda Expected Within 30 Days; New Pdufa Date in 6 Months","url":"https://stock-news.laohu8.com/highlight/detail?id=2671521637","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671521637?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:05","pubTimestamp":1790679900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA84XFVD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","UNCY","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671216374","title":"Unicycive Therapeutics - Nda Resubmission Includes Cmc Data from New Manufacturing Vendor","url":"https://stock-news.laohu8.com/highlight/detail?id=2671216374","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671216374?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:05","pubTimestamp":1790679900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA84XFVD:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","UNCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671216370","title":"Unicycive Therapeutics Announces Resubmission of New Drug Application for Oxylanthanum Carbonate","url":"https://stock-news.laohu8.com/highlight/detail?id=2671216370","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671216370?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:05","pubTimestamp":1790679900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA84XFVD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","UNCY","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671216306","title":"Unicycive Therapeutics - FDA Inspection of Original Manufacturing Vendor Assigned but not Completed as of Sept 29, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2671216306","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671216306?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:05","pubTimestamp":1790679900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA84XFVD:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","UNCY","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671216388","title":"Invivyd Says Liberty Phase 3 Trial Shows Vyd2311 Safety, Tolerability Top mRNA COVID-19 Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2671216388","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671216388?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:04","pubTimestamp":1790679843,"startTime":"0","endTime":"0","summary":"Invivyd says LIBERTY Phase 3 trial shows VYD2311 safety, tolerability top mRNA COVID-19 vaccineInvivyd reported positive topline Phase 3 LIBERTY results for VYD2311, already released, showing better s","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL9g3Y2d:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","SG9999014021.USD","BK4112","IE00BQXX3D17.EUR","BK4139","IE00BQXX3F31.USD","LU2095319765.USD","NDAQ","BK4588","IE00B64PRP62.GBP","LU0314104364.USD","LU2210149790.SGD","SG9999014013.SGD","IE00BGHQF748.EUR","IE00BN0W2W23.USD","IE00BQXX3C00.GBP","IE00BN0W2V16.EUR","LU2210150020.SGD","BK4585","IE00BKPKM429.USD","IE00B3QW5Z07.USD","SG9999014005.SGD","IE00BN0W2T93.GBP","IVVD","BK4539","BCDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671786215","title":"Invivyd, - Vyd2311 Combined with Mrna Covid-19 Vaccine Adds to Neutralizing Titers Without Interference","url":"https://stock-news.laohu8.com/highlight/detail?id=2671786215","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671786215?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:01","pubTimestamp":1790679660,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA9SJPNV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","IVVD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671215034","title":"Invivyd, - Plans Bla Submission for Vyd2311 to FDA Via Accelerated Approval Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2671215034","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671215034?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:01","pubTimestamp":1790679660,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA9SJPNV:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IVVD","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671021573","title":"Invivyd Announces Positive Topline Results from Liberty Phase 3 Study Demonstrating Vyd2311 Safety and Tolerability Superior to Mrna-Based Covid-19 Vaccine; Announces Regulatory Submission Plans for Vyd2311","url":"https://stock-news.laohu8.com/highlight/detail?id=2671021573","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671021573?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:01","pubTimestamp":1790679660,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA9SJPNV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","IVVD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671249215","title":"Press Release: Aquestive Therapeutics Strengthens Board of Directors with Appointment of Richard Daly","url":"https://stock-news.laohu8.com/highlight/detail?id=2671249215","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671249215?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:00","pubTimestamp":1790679600,"startTime":"0","endTime":"0","summary":"Appoints Rich Daly, a life sciences executive with more than 30 years of leadership experience across large pharmaceutical companies, emerging biotechnology companies, and public company boards, to it","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TM","AQST","BK4539","LNGR","BK4007","LENZ","R","BK4099","IEIH","03160","BK4588","BK4604","BK4555","BK4022","CDMO","BK4232","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671215747","title":"Alzamend Neuro Highlights Early AL001 Brain Lithium Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2671215747","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671215747?lang=en_us&edition=fundamental","pubTime":"2026-09-29 18:57","pubTimestamp":1790679473,"startTime":"0","endTime":"0","summary":"An update from Alzamend Neuro ( ($ALZN) ) is now available. Alzamend Neuro, Inc. is a clinical-stage biopharmaceutical company pursuing lithium-bas...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alzamend-neuro-highlights-early-al001-brain-lithium-data?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alzamend-neuro-highlights-early-al001-brain-lithium-data?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TESC","TSLY","TSLI","07366","TSDD","BK4539","TSL","TSLW","TSLG","SETM","TSLL","BK4516","TSLO","TSLT","09766","TLA","ELOL","TSLP","CRSH","FXZ","LIT","TEST","09366","BK4585","BK4139","TESL","BK4588","07766","TSLZ","TSII","TSLS","TSLR","ALZN","TSLQ","TSYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671213076","title":"Presidio Names J. Michael Bruff CFO Effective Oct. 5","url":"https://stock-news.laohu8.com/highlight/detail?id=2671213076","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671213076?lang=en_us&edition=fundamental","pubTime":"2026-09-29 18:35","pubTimestamp":1790678101,"startTime":"0","endTime":"0","summary":"Presidio names J. Michael Bruff CFO effective Oct. 5Presidio named J. Michael Bruff as chief financial officer, effective Oct. 5, 2026.Bruff was most recently CFO of Envision Healthcare. He previously","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL2STPz5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFST","FMED","BK4196","BK4535","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671521536","title":"Summit Therapeutics secures major AstraZeneca equity partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2671521536","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671521536?lang=en_us&edition=fundamental","pubTime":"2026-09-29 18:31","pubTimestamp":1790677914,"startTime":"0","endTime":"0","summary":"Summit Therapeutics ( ($SMMT) ) has issued an announcement. On September 28, 2026, Summit Therapeutics entered into a securities purchase agreement...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/summit-therapeutics-secures-major-astrazeneca-equity-partnership?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/summit-therapeutics-secures-major-astrazeneca-equity-partnership?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4007","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671215550","title":"Analysts Conflicted on These Technology Names: Duolingo (DUOL), Advanced Micro Devices (AMD) and Draganfly (DPRO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671215550","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671215550?lang=en_us&edition=fundamental","pubTime":"2026-09-29 18:30","pubTimestamp":1790677840,"startTime":"0","endTime":"0","summary":"Companies in the Technology sector have received a lot of coverage today as analysts weigh in on Duolingo (DUOL), Advanced Micro Devices (AMD) and ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-technology-names-duolingo-duol-advanced-micro-devices-amd-and-draganfly-dpro-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-technology-names-duolingo-duol-advanced-micro-devices-amd-and-draganfly-dpro-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4529","LU0823421416.USD","LU2896262040.SGD","WUGI","LU2543165471.USD","LU0048584097.USD","LU1989764748.USD","LU2461242641.AUD","LU1804176565.USD","LU2108987350.USD","LU1242518857.USD","TTEQ","IE00B1BXHZ80.USD","LU2250418816.HKD","LU2417539215.USD","LU1989764664.SGD","SMH","BK4588","LU2236285917.USD","LU1803068979.SGD","LU0979878070.USD","QQQA","BK4614","DUOL","IE00BQXX3F31.USD","LU0251132253.USD","LU2456880835.USD","BK4554","DAMD","LU0109392836.USD","LU1923623000.USD","LU0127658192.USD","IE00BKVL7J92.USD","BAI","LU2361045086.USD","CHPS","BK4585","LU2361044949.HKD","LU0823421333.USD","BK4532","LU1861220033.SGD","LU0174119429.USD","LU0109391861.USD","TRFK","DPRO","LU0274383776.USD","DUOG","LU1232071149.USD","PSI","GAMR","LU1989772840.SGD","LU1303367103.USD","USXF","LU0056508442.USD","FTXL","LU0823434583.USD","LU2264538146.SGD","LU1064131342.USD","LU2360107168.USD","SGXZ51526630.SGD","LU2462591350.SGD","LU1267930730.SGD","LU2265009873.SGD","WISE","AMUU","LU2242649171.HKD","BK4512","LU1951200564.SGD","LU0719512351.SGD","BK4613","LU0708995401.HKD","LU2458330243.SGD","LU2098885051.SGD","IETC","AMD","LU0210536198.USD","LU1951198990.SGD","LEGR","ARTY","BK4573","FAI","AIS","IE0009356076.USD","SGXZ81514606.USD","LU1989772923.USD","BK4603","LU2360106780.USD","LU1880398554.USD","BK4575","IE00BQXX3D17.EUR","LU2089985449.USD","BK4204","BK4605","LU1988902786.USD","LU2054465674.USD","SOXY","BK4539","BK4566","LU0889565833.HKD","BK4534","SG9999001424.SGD","LU2290526834.HKD","LU1852331112.SGD","LU1861215975.USD","IE00BMPRXN33.USD","LU1267930813.SGD","LU0792757196.USD","IE00BQXX3C00.GBP","BK4187","SGXZ99366536.SGD","IE00BMPRXR70.SGD","BK4612","LU0081259029.USD","LU2860962120.EUR","LU2247934214.USD","LU2355687059.USD","SOXX","LU0823434740.USD","AMYY","BK4543","AMDY","IE00B5949003.HKD","LU2931357623.SGD","IE00BZ1G4Q59.USD","IE0004445239.USD","AMDS","LU1861559042.SGD","AMDW","LU0390134368.USD","LU1880398471.USD","CNAV","CHAT","LU0786609619.USD","ILDR","LU0082616367.USD","LU0133085943.USD","AMDL","LU0672654240.SGD","AIQ","AMDG","LU0348723411.USD","AMDC","IE00BMPRXQ63.HKD","LU1316542783.SGD","LU2458330169.SGD","LU0198837287.USD","IE0001KFT4U8.USD","LU1242518931.SGD","AMDU","SMHX","AMDD","LU2361044865.SGD","LU0320765059.SGD","BK4141","TEK","XNTK","SAMD0main","LU0642271901.SGD","LU0889566641.SGD","LU1861558580.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":41,"pageCount":35,"totalSize":801,"code":"91000000","status":"200"}]}}